Ontology highlight
ABSTRACT:
SUBMITTER: Shinder BM
PROVIDER: S-EPMC5449498 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature
Shinder Brian M BM Rhee Kevin K Farrell Douglas D Farber Nicholas J NJ Stein Mark N MN Jang Thomas L TL Singer Eric A EA
Frontiers in oncology 20170531
The past decade has seen a rapid proliferation in the number and types of systemic therapies available for renal cell carcinoma. However, surgery remains an integral component of the therapeutic armamentarium for advanced and metastatic kidney cancer. Cytoreductive surgery followed by adjuvant cytokine-based immunotherapy (predominantly high-dose interleukin 2) has largely given way to systemic-targeted therapies. Metastasectomy also has a role in carefully selected patients. Additionally, neoad ...[more]